MedPath

TRAVATAN

Brand Name: TRAVATAN

Generic Name: TRAVOPROST

Active
Registration Number

DR-XY27388

Dosage Form

Sterile Ophthalmic Solution

Issuance Date

August 2, 2022

Expiry Date

November 23, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40mcg/ mL (0.004% w/v)
PackagingPolypropylene oval droptainer x 2.5mL (box of 1's); Polypropylene oval droptainer x 1.5mL (box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
A
Application
Automatic Renewal (Variation) re-issuance
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

TRAVOPROSTActive
Monograph: Travoprost

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform